Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine-N-butylbromide for shortening the active phase of labour in primigravidae
PACTR202111520130772Phase 0Recruiting
- Sponsor
- Dr. Aniekan Jackson
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, double-blind trial comparing Hyoscine-N-butylbromide with Placebo (2 arms). Primary endpoint: Duration of active phase of labour. Started Nov 2021; status: recruiting.
02
Drugs
hyoscine butylbromide
Beyond the preview
Go deeper on PACTR202111520130772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202111520130772.